What is Dexibuprofen used for?

Dexibuprofen, a non-steroidal anti-inflammatory drug (NSAID), has emerged as a potent and effective medication in the treatment of pain and inflammation. Marketed under various trade names such as Seractil, Dexopir, and Dexibron, dexibuprofen targets cyclooxygenase enzymes (COX-1 and COX-2) to exert its therapeutic effects. Research institutions and pharmaceutical companies have been actively exploring the potential of dexibuprofen, conducting clinical trials and studies to better understand its efficacy and safety profile. As an enantiomer of ibuprofen, dexibuprofen offers several advantages, including better tolerability and potentially enhanced effectiveness. Indications for dexibuprofen include the management of acute pain, chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis, and dysmenorrhea. The research progress on dexibuprofen has been promising, with numerous studies highlighting its benefits over traditional NSAIDs.

Dexibuprofen exerts its effects by selectively inhibiting the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. These enzymes play a crucial role in the biosynthesis of prostaglandins, which are lipid compounds that mediate various physiological processes, including inflammation, pain, and fever. By inhibiting COX enzymes, dexibuprofen reduces the production of prostaglandins, thereby alleviating inflammation and pain. Unlike traditional ibuprofen, which is a racemic mixture of R- and S-enantiomers, dexibuprofen consists solely of the active S-enantiomer, which is responsible for its therapeutic effects. This selective inhibition allows dexibuprofen to provide potent anti-inflammatory and analgesic effects while potentially reducing gastrointestinal side effects associated with non-selective COX inhibition.

 

Researching Dexibuprofen beyond the basics?

Synapse Hiro LS Researcher, the Synapse AI Insight Engine, is built to accelerate biopharma decisions. Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence. Explore Dexibuprofen with Hiro LS Researcher →

Dexibuprofen is typically administered orally in the form of tablets, capsules, or suspensions. The dosage and frequency of administration depend on the severity of the condition being treated and the patient's response to the medication. For acute pain management, a common starting dose is 400 mg taken up to three times a day. For chronic inflammatory conditions, the dosage may be adjusted based on the patient's needs and tolerability. Dexibuprofen is rapidly absorbed from the gastrointestinal tract, and peak plasma concentrations are usually reached within 1 to 2 hours after ingestion. The onset of action typically occurs within 30 minutes to 1 hour, providing relatively quick relief from pain and inflammation. It is recommended to take dexibuprofen with food or milk to minimize potential gastrointestinal discomfort.

Like any medication, dexibuprofen can cause side effects, although not everyone experiences them. Common side effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain. These symptoms are generally mild and tend to resolve with continued use or dose adjustment. More serious gastrointestinal side effects, such as ulcers, bleeding, and perforation, can occur but are less common. To minimize the risk of these adverse events, it is important to use the lowest effective dose for the shortest duration necessary. Cardiovascular side effects, including hypertension and an increased risk of heart attack and stroke, have been reported with NSAIDs, including dexibuprofen. Patients with a history of cardiovascular disease or risk factors should use dexibuprofen with caution and under the guidance of a healthcare professional. Other potential side effects include allergic reactions, liver and kidney function abnormalities, and hematologic effects such as anemia and thrombocytopenia. Contraindications for dexibuprofen use include known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal bleeding or peptic ulcer disease, severe heart failure, and significant renal or hepatic impairment.

Dexibuprofen can interact with various other medications, potentially affecting its efficacy and safety. Concomitant use of dexibuprofen with other NSAIDs, including aspirin, can increase the risk of gastrointestinal and cardiovascular side effects. It is generally recommended to avoid using multiple NSAIDs simultaneously. Dexibuprofen can also interact with anticoagulants such as warfarin, increasing the risk of bleeding. Patients taking anticoagulants should be closely monitored and may require dose adjustments. The use of dexibuprofen with antihypertensive medications, including ACE inhibitors, angiotensin II receptor blockers, and diuretics, can reduce the effectiveness of these drugs and may lead to an increase in blood pressure. Additionally, dexibuprofen can enhance the nephrotoxic effects of certain medications, such as cyclosporine and tacrolimus, potentially leading to kidney damage. Patients on these medications should be monitored for renal function and may require dose adjustments. It is important to inform healthcare providers of all medications, including over-the-counter drugs and supplements, to avoid potential drug interactions and ensure the safe and effective use of dexibuprofen.

In conclusion, dexibuprofen is a valuable NSAID that offers effective pain relief and anti-inflammatory benefits. Its selective action on COX enzymes, combined with its improved safety profile, makes it a preferred choice for many patients. However, like all medications, dexibuprofen requires careful consideration of potential side effects, contraindications, and drug interactions. By working closely with healthcare providers, patients can optimize the benefits of dexibuprofen while minimizing potential risks, ensuring a safe and effective treatment experience.

Continue your Dexibuprofen research with Synapse Hiro LS Researcher

This article provides an overview. For a broader research view, use Synapse Hiro LS Researcher—the Synapse AI Insight Engine—to search across drugs, targets, indications, clinical trials, literature, organizations, news, deals, and competitor signals. Ask any biopharma research question in natural language.

Questions to explore:

• What approved and investigational uses have been reported for Dexibuprofen?
• What is the mechanism of action of Dexibuprofen, and which targets or pathways are involved?
• Which clinical trials are evaluating Dexibuprofen, and what outcomes have been reported?
• What patents, publications, and regulatory sources provide the latest evidence on Dexibuprofen?

Ask Synapse Hiro LS Researcher →

AI may make mistakes. Check important info.